TAB, not sure if this has ever been brought up, as I don't recall seeing anything ever since the announcement first came out, but I noticed something interesting when diving into some DD on PKG.
Warsaw Equity Group has been involved w/ PKG, and WEG's Investment Director, Adam Marikel, currently serves as a Supervisory Board Member. I first noticed Adam's name on the Bloomberg profile for PKG. On WEG's website, the following information is provided on Adam:
He is responsible for sourcing and evaluation of investment projects, preparation of business and market analyses as well as strategic supervision of portfolio companies. Adam provides ongoing support to Artifex Mundi, Clearcode, ZMorph, PKG, Vigo System and Vigo WE Innovation. He started his professional career in the equity research department of Merrill Lynch and in the years 2008 – 2019 was part of the investment banking team of Trigon Group where he was involved in a number of M&A transactions as well as both public and private equity and corporate debt raisings. He currently serves at the Supervisory Boards of Clearcode, ZMorph and PKG.
Found it interesting since a lot of trials are performed throughout Poland and other countries throughout the EU. Also found it interesting since he was involved with M&A transactions with his previous company, Trigon. Could be a coincidence but thought it might be relevant to share and get others take.